thiazoles has been researched along with abt 299 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, DH; Carter, GW; Conway, RG; Davidsen, SK; Holms, JH; Luo, G; Magoc, TJ; Rhein, DA; Summers, JB; Tapang, P | 2 |
| Albert, DH; Carter, GW; Grossman, JE; Kruse-Elliott, KT; Summers, JB; Zimmerman, JJ | 1 |
| Albert, DH; Carter, GW; Davidsen, SK; Holms, JH; Luo, G; Magoc, TJ; Summers, JB; Tapang, P | 1 |
| Albert, DH; Carter, GW; Kleinert, HD; Magoc, TJ; Reyes, AE; Summers, JB; Sun, E | 1 |
| Albert, DH; Carter, GW; Kleinert, HD; Magoc, TJ; Menacherry, SD; Morgan, DW; Reyes, AE; Summers, JB; Sun, E | 1 |
| Lefferts, PL; Lu, W; Snapper, JR; Thabes, JS | 1 |
2 trial(s) available for thiazoles and abt 299
| Article | Year |
|---|---|
Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonist.
Topics: Adolescent; Adult; beta-Thromboglobulin; Chromatography, High Pressure Liquid; Double-Blind Method; Humans; Injections, Intravenous; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prodrugs; Pyridinium Compounds; Spectrophotometry, Ultraviolet; Thiazoles | 1996 |
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist.
Topics: Adolescent; Adult; beta-Thromboglobulin; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Humans; In Vitro Techniques; Indoles; Injections, Intravenous; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prodrugs; Pyridinium Compounds; Thiazoles | 1997 |
5 other study(ies) available for thiazoles and abt 299
| Article | Year |
|---|---|
ABT-299, a potent antagonist of platelet activating factor.
Topics: Animals; Binding, Competitive; Blood Pressure; Edema; Esterases; Humans; Hypotension; Indoles; Kinetics; Lipopolysaccharides; Mice; Molecular Structure; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prodrugs; Pyridinium Compounds; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Thiazoles | 1995 |
Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist.
Topics: Animals; Binding, Competitive; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Kinetics; Mice; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prodrugs; Pyridinium Compounds; Rabbits; Rats; Thiazoles | 1996 |
Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist.
Topics: Animals; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Lipopolysaccharides; Lung; Peroxidase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prodrugs; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Stroke Volume; Swine; Thiazoles; Thromboxane B2; Vascular Resistance | 1996 |
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats.
Topics: Animals; Consciousness; Disseminated Intravascular Coagulation; Endotoxemia; Endotoxins; Gastrointestinal Hemorrhage; Hypotension; Lipopolysaccharides; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Teichoic Acids; Thiazoles | 1996 |
Effect of platelet-activating factor-receptor antagonism on endotoxin-induced lung dysfunction in sheep.
Topics: Animals; Blood Pressure; Endotoxins; Humans; Infant, Newborn; Leukocyte Count; Lung; Oxygen; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prodrugs; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Sheep; Thiazoles | 1998 |